Research Library

Retatrutide targets GIP, GLP-1, and glucagon receptors simultaneously — the only compound in its class with that full triple mechanism. Phase II data showed weight reduction metrics that outperformed dual-agonist comparators in the same cohort. For researchers studying receptor selectivity or comparative metabolic agonism, it has become a benchmark compound. BlankChem’s batch is ≥99% purity, independently verified by HPLC and LC-MS/MS.

BPC-157 is a 15-amino acid partial sequence derived from body protection compound found in gastric juice. Preclinical studies have examined its interaction with the growth hormone receptor, nitric oxide synthesis pathways, and tendon/ligament fibroblast activity. Unlike most peptides, its stability profile allows for certain research protocols that would otherwise require more careful handling conditions.

TB-500 is a synthetic analog of the 17–23 amino acid segment of Thymosin Beta-4. Research has focused on its ability to sequester G-actin, promote cell migration, and modulate inflammatory cytokines in tissue remodeling models. Its lower molecular weight relative to full TB4 makes it a preferred research tool when working with receptor binding studies or dose-response protocols.

Several preclinical studies have examined BPC-157 and TB-500 in concurrent protocols, noting complementary mechanisms — BPC-157 acting through GH receptor pathways while TB-500 engages actin dynamics and cell migration. Our pre-combined lyophilized blend simplifies your research setup and eliminates the need for separate reconstitution. Saves 12% versus buying each individually.

GHK-Cu has been studied for its effects on fibroblast proliferation, collagen and glycosaminoglycan synthesis, and antioxidant enzyme upregulation including superoxide dismutase. Its copper chelation mechanism distinguishes it from standard peptide compounds and has driven significant interest in dermal and systemic research applications. Available lyophilized at ≥98% purity.

Semax is a synthetic heptapeptide analog of ACTH(4-10) studied for its ability to upregulate BDNF and NGF expression in rodent hippocampal models. Its structural stability relative to native ACTH fragments makes it suitable for longer-duration protocols without enzymatic degradation concerns — a key advantage in neuropeptide research settings.

Bromantane’s dual mechanism — stimulating tyrosine hydroxylase gene expression to increase dopamine synthesis while also interacting with GABA-A receptors — sets it apart from standard stimulants. Originally developed as a military performance compound, it has since become a subject of fatigue-resistance and adaptogen research. Available as API powder at ≥98% purity.

Selank is a synthetic hexapeptide analog of the immunomodulatory peptide Tuftsin (TKPR). Research has proposed that it inhibits enkephalin-degrading enzymes, prolonging natural opioid peptide activity at receptor sites. Alongside GABA-A modulation data, this forms the basis of its studied anxiolytic profile in rodent models. Lyophilized at ≥98% purity.